Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial : a randomised controlled trial


Autoria(s): Pyle, Melissa; Norrie, John; Schwannauer, Matthias; Kingdon, David; Gumley, Andrew; Turkington, Douglas; Byrne, Rory; Syrett, Suzy; MacLennan, Graeme; Dudley, Robert; McLeod, Hamish J; Griffiths, Helen; Bowe, Samantha; Barnes, Thomas R E; French, Paul; Hutton, Paul; Davies, Linda; Morrison, Anthony P
Contribuinte(s)

University of Aberdeen, Medicine, Medical Sciences & Nutrition, HSRU

Data(s)

20/09/2016

20/09/2016

05/08/2016

Resumo

Acknowledgements Thank you to all the participants who agreed to take part in the trial. This study was supported NHS Research Scotland (NRS), through Chief Scientist Office (CSO) and the Scottish Mental Health Research Network, and the Clinical Research Network-Mental Health. We are grateful to the Psychosis Research Unit (PRU) Service User Reference Group (SURG) for their consultation regarding the design of the study and contribution to the developments of study related materials. We are grateful to our Independent Trial Steering Committee and Independent Data Monitoring Committee for provided oversight of the trial. Funding This project was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme (project number10/101/02) and will be published in full in Health Technology Assessment. Visit the HTA programme website for further project information. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS or the Department of Health.

Peer reviewed

Publisher PDF

Identificador

Pyle , M , Norrie , J , Schwannauer , M , Kingdon , D , Gumley , A , Turkington , D , Byrne , R , Syrett , S , MacLennan , G , Dudley , R , McLeod , H J , Griffiths , H , Bowe , S , Barnes , T R E , French , P , Hutton , P , Davies , L & Morrison , A P 2016 , ' Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial : a randomised controlled trial ' BMC Psychiatry , vol 16 , 280 . , 10.1186/s12888-016-0983-6

1471-244

PURE: 70813129

PURE UUID: 530e0b42-6898-42c1-9063-814170dc8c72

PubMed: 27496180

http://hdl.handle.net/2164/7496

http://dx.doi.org/10.1186/s12888-016-0983-6

Idioma(s)

eng

Relação

BMC Psychiatry

Direitos

© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Palavras-Chave #Schizophrenia #Psychosis #Clozapine-resistant #Cognitive behavioural therapy #Randomised controlled trial #R Medicine #National Institute for Health Research (NIHR) #R
Tipo

Journal article